Browsing "Hematology-Oncology" by Keyword : Risk Factors

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:
  • Sort by:
  • In order:
  • Results/Page
  • Authors/Record:

Showing results 1 to 9 of 9

Pub YearTitleAuthor(s)
20135-Fluorouracil, mitomycin-c, and polysaccharide-k versus uracil-ftorafur and polysaccharide-K as adjuvant chemoimmunotherapy for patients with locally advanced gastric cancer with curative resection.강석윤, 박준성, 안미선, 이광재, 이순영, 이현우, 정성현, 조용관, 최진혁, 한상욱
2016A multicenter phase II study of sorafenib in combination with erlotinib in patients with advanced non-small cell lung cancer (KCSG-0806)강석윤, 최진혁
1996A multicentre comparison of once-daily subcutaneous dalteparin (low molecular weight heparin) and continuous intravenous heparin in the treatment of deep vein thrombosis.김효철
2015A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome.정성현
1997Association of hemostatic factors with peripheral vascular disease.김효철
2019Clinical Outcomes of Decitabine Treatment for Patients With Lower-Risk Myelodysplastic Syndrome on the Basis of the International Prognostic Scoring System정성현
2021Early removal of central venous catheter may not impact the in-hospital mortality in patients with acute leukemia강석윤, 김태환, 박준성, 안미선, 이현우, 정성현, 최용원, 최윤석, 최진혁
2015Is fourth-line chemotherapy routine practice in advanced non-small cell lung cancer?강석윤, 박준성, 안미선, 이순영, 이현우, 정성현, 최용원, 최진혁
2014Patterns of neutropenia and risk factors for febrile neutropenia of diffuse large B-cell lymphoma patients treated with rituximab-CHOP.강석윤, 박준성, 안미선, 이현우, 정성현, 최용원, 최진혁
1

Browse